See all Profiles
Headshot photo of La'Marcus T. Wingate

La'Marcus T. Wingate

Associate Professor

  • Clinical & Administrative Pharmacy Sciences
  • College of Pharmacy


Dr. Wingate is an associate professor in the Department of Clinical and Administrative Pharmacy Sciences. He received his PharmD and Ph.D. in Health Outcomes and Policy Research from the University of Tennessee Health Science Center in Memphis, Tennessee. After completing this training, Dr. Wingate completed the CDC Prevention Effectiveness Fellowship in Atlanta, GA.  Dr. Wingate began his career at Howard Universit in 2014.Dr. Wingate is a co-investigator for the Howard University National Workforce Diversity Program funded by the Office of Minority Health. This is a program designed to develop and implement strategies to increase the number of underrepresented minorities entering into the science, technology, and engineering related fields.Dr. Wingate research interests are in patient reported health outcomes and economic evaluations of public health programs, with an emphasis on those that focus on infectious disease.  More specifically, Dr. Wingate has focused on programs focused on the prevention and treatment of tuberculosis in populations immigrating to the U.S.Dr. Wingate also has emerging interest in health behaviors and their impact on obesity within minority communities as he is a part of the NIH funded Obesity Health Disparities program.

Education & Expertise



Clemson University


University of Tennessee Health Science Center

Health Outcomes and Policy Research

University of Tennessee Health Science Center



Pharmacoepidemiology & Outcomes Research

The Pharmacoepidemiology and Outcomes Research section is an introduction to the evaluation of the scientific studies that supports the rational use of medication use in humans.  The goals of this block is to provide opportunities for students to understand the concepts, methods, and applications of pharmacoepidemiology, pharmacoeconomics, and outcomes studies utilized in clinical settings as well as with to provide tools to critically assess the clinical literature.  In addition, the methods for the interpretational and generalization of findings from these studies relevant to medical and pharmaceutical care practice will be introduced by utilizing knowledge developed from the Research Methods/Biostatistics block.  Students will be also prepared for problem-based critique sessions in the Integrative Therapeutics blocks.